Reckitt Benckiser Group plc (LON:RKT)

Market Cap	35.21B
Revenue (ttm)	14.17B
Net Income (ttm)	1.43B
Shares Out	683.88M
EPS (ttm)	2.03
PE Ratio	25.26
Forward PE	14.86
Dividend	2.02 (3.94%)
Ex-Dividend Date	Apr 10, 2025

Volume	1,731,282
Average Volume	1,547,129
Open	5,146.00
Previous Close	5,130.00
Day's Range	5,138.00 - 5,208.00
52-Week Range	4,034.00 - 5,418.00
Beta	0.07
RSI	47.21
Earnings Date	Mar 6, 2025

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet bra...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1819
• Employees: 40,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: RKT

Financial Performance

In 2024, Reckitt Benckiser Group's revenue was 14.17 billion, a decrease of -3.00% compared to the previous year's 14.61 billion. Earnings were 1.43 billion, a decrease of -13.21%.